Knee pain, a common problem for millions, might be relieved for up to a year through a non-surgical method identified in recent research. This emerging treatment, known as genicular artery embolization (GAE), targets abnormal blood vessels in individuals suffering from osteoarthritis.
Studies conducted in Germany indicate that this embolization approach is both safe and offers significant, lasting relief from pain while also improving function for those dealing with knee pain linked to osteoarthritis.
Osteoarthritis itself is quite prevalent and, according to the World Health Organization, affects over 365 million adults worldwide. It leads to inflammation, stiffness, reduced mobility, and nerve pain, making it one of the major contributors to disability globally.
Florian Fleckenstein, leading the study, emphasized that current treatments often fall short. Conservative approaches, like injections, may not yield adequate relief, while joint replacements can be impractical for many due to various personal or medical reasons. GAE focuses specifically on these problematic blood vessels through a method termed “superselective embolization.” This process involves a radiologist using a tiny catheter to directly access and block these vessels, thus reducing inflammation and alleviating pain without the need for invasive surgery.
The hypothesis behind GAE is intriguing: utilizing gelatin-based microspheres that are designed to dissolve quickly could combine the advantages of both temporary and permanent embolic agents, while mitigating their downsides. These resorbable microspheres, crafted to dissolve in hours, seem quite promising.
Fleckenstein noted that GAE represents a novel treatment pathway, modifying the neurovascular environment associated with osteoarthritis by targeting excessive blood vessel growth. This approach appears to also slow the disease’s progression, which is—at least in my view—an encouraging step forward.
The study involved 194 participants (114 women and 80 men) averaging 69 years old who hadn’t found relief after regular treatments lasting at least three months, including physical therapy and anti-inflammatory drugs. They underwent GAE with these resorbable microspheres from July to November 2024.
Interestingly, around 23% of those involved had two GAE procedures for bilateral knee osteoarthritis within a month. Overall, 239 successful GAE procedures were performed, all guided by imaging techniques.
It’s worth noting that there were no significant complications; only mild reactions were reported in about 6.7% of the subjects. The outcomes were assessed at various intervals following the treatment.
The findings, which were published in the journal *Radiology*, indicated a notable decrease in pain scores—starting at seven out of ten, dropping to four at six weeks and then to three at the six- and twelve-month marks. More than 80% of participants observed substantial improvements by the end of the study period.
Fleckenstein expressed confidence in the results, stating that GAE combined with the innovative microspheres proved to be a safe and effective option that leads to meaningful pain relief and enhanced functionality for people experiencing knee symptoms tied to osteoarthritis. He highlighted that this method could represent a significant development for patients seeking alternatives to injections and joint replacement.
